Cargando…
The Fibrillin‐1/VEGFR2/STAT2 signaling axis promotes chemoresistance via modulating glycolysis and angiogenesis in ovarian cancer organoids and cells
BACKGROUND: Chemotherapy resistance is a primary reason of ovarian cancer therapy failure; hence it is important to investigate the underlying mechanisms of chemotherapy resistance and develop novel potential therapeutic targets. METHODS: RNA sequencing of cisplatin‐resistant and ‐sensitive (chemore...
Autores principales: | Wang, Ziliang, Chen, Wei, Zuo, Ling, Xu, Midie, Wu, Yong, Huang, Jiami, Zhang, Xu, Li, Yongheng, Wang, Jing, Chen, Jing, Wang, Husheng, Sun, Huizhen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8923131/ https://www.ncbi.nlm.nih.gov/pubmed/35234370 http://dx.doi.org/10.1002/cac2.12274 |
Ejemplares similares
-
Programmed death ligand‐1 regulates angiogenesis and metastasis by participating in the c‐JUN/VEGFR2 signaling axis in ovarian cancer
por: Yang, Yufei, et al.
Publicado: (2021) -
Aurora-A/SOX8/FOXK1 signaling axis promotes chemoresistance via suppression of cell senescence and induction of glucose metabolism in ovarian cancer organoids and cells
por: Sun, Huizhen, et al.
Publicado: (2020) -
Lnc-RP11-536 K7.3/SOX2/HIF-1α signaling axis regulates oxaliplatin resistance in patient-derived colorectal cancer organoids
por: Li, Qingguo, et al.
Publicado: (2021) -
Stanniocalcin-2 promotes cell EMT and glycolysis via activating ITGB2/FAK/SOX6 signaling pathway in nasopharyngeal carcinoma
por: Li, Jingquan, et al.
Publicado: (2021) -
Discovery of a highly selective VEGFR2 kinase inhibitor CHMFL-VEGFR2-002 as a novel anti-angiogenesis agent
por: Jiang, Zongru, et al.
Publicado: (2020)